A Phase 1, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Local Administration of EXPAREL When Administered for Prolonged Postsurgical Analgesia in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery
Phase of Trial: Phase I
Latest Information Update: 05 May 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 28 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jul 2017.
- 28 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jul 2017.
- 24 Jan 2017 Status changed from not yet recruiting to recruiting.